NCT02323893View on ClinicalTrials.gov

Study of Kinetics, Dosimetry & Safety of [18F]F-AraG, a Positron Emission Tomography Imaging Tracer in Healthy Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Cancer
Interventions
DRUG

[18F]F-AraG

Trial Locations (1)

94107

UCSF Imaging Center at China Basin, San Francisco

Sponsors
All Listed Sponsors
lead

CellSight Technologies, Inc.

INDUSTRY